1. EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling. Issue 11 (25th October 2018) Authors: Linder, Markus; Glitzner, Elisabeth; Srivatsa, Sriram; Bakiri, Latifa; Matsuoka, Kazuhiko; Shahrouzi, Parastoo; Dumanic, Monika; Novoszel, Philipp; Mohr, Thomas; Langer, Oliver; Wanek, Thomas; Mitterhauser, Markus; Wagner, Erwin F; Sibilia, Maria Journal: EMBO molecular medicine Issue: Volume 10:Issue 11(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗